Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $110.81. The company's market cap stands at 275.41B, with a P/E ratio of 14.32 and a dividend yield of 3.0%.
As of 2026-01-15, Merck(MRK) stock has fluctuated between $108.45 and $111.58. The current price stands at $110.81, placing the stock +2.2% above today's low and -0.7% off the high.
The Merck(MRK)'s current trading volume is 11.77M, compared to an average daily volume of 12.75M.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
MRK News
Advertisement Merck stock reaction and recent return profile Merck (MRK) has drawn investor attention after a stretch of mixed short term performance, with a...
At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025. Revolution Medici...
AbbVie ABBV announced that it has signed an agreement with the Trump administration to lower drug prices in the United States. Under the agreement, AbbVie has...
Analyst ratings
57%
of 28 ratingsMore MRK News
Illumina (ILMN) introduced the world’s largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through AI across the pharmace...
Pharma giant Merck (MRK) is targeting $70 billion in revenue from new growth drivers by the mid-2030s, as the company accelerates the launch of new drugs to mit...
Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.83% in the past week. It has experienced a 5-day net inflow of $70.23 million. This is due, in part, to...
The company might become the latest biotech acquisition story soon. More often than not, takeover speculation can give a lively boost -- at least in the short...
Merck (MRK) is in talks to purchase Revolution Medicines (RVBD) for about $30 billion. Shares of Revolution Medicines jumped 11%. A deal for the cancer-drug bi...
Merck (MRK) is in talks to acquire Revolution Medicines (RVMD) in a deal that could value it at around $30B as the pharma giant has been discussing a deal value...
Revolution Medicines CEO Mark Goldsmith in 2020. Mark Kauzlarich/Bloomberg News Merck MRK 0.20 %increase; green up pointing triangle is in talks to acquire Rev...
